October 2017

Letter from the Editor

October 1, 2017

Connected Health At this month’s 2017 Connected Health Conference to be held in Boston, industry leaders will gather to discuss a multitude of topics that are focused on improving health outcomes by accelerating the adoption of personal connected health. A couple of the major themes to be discussed surround wearables, IoT, and natural language in […]

Upfront

October 1, 2017

Amgen Foundation Expands the Amgen Biotech Experience The Amgen Foundation is expanding the Amgen Biotech Experience (ABE) to reach nearly 900,000 high school students by 2020. The program will launch in nine new markets: Australia, Canada, China, France, Germany, Hong Kong SAR, Italy, Netherlands, and Singapore. The program will continue in key markets in the […]

HealthTech

October 1, 2017

Wearable Healthcare: Beyond Smartwatches and Fitness Trackers Trend Watch: Next-gen wearable healthcare will be nano sensors. ABI Research forecasts that wearable healthcare, including healthcare devices, sports, fitness, and wellness trackers will continue to dominate the wearables market and will exceed revenue of $10 billion in 2022. Healthcare will shrink in size and change in form […]

Innovator’s Corner

October 1, 2017

Using Electric Fields to Treat Cancer Bill Doyle, Executive Chairman of Novocure, talks about the company’s treatment that uses electric fields to treat glioblastoma, a deadly brain cancer, and other cancers. Novocure’s approach to treating cancer may look like pseudo science, but the results are real. Novocure is using low intensity, alternating electric fields to […]

Last Word

October 1, 2017

Pharma’s Role in the Community John Damonti, President of the Bristol-Myers Squibb Foundation and VP of Corporate Philanthropy at Bristol-Myers Squibb, talks about how his company and other pharmaceutical companies can provide relief during disasters, such as Hurricanes Harvey and Irma. PV: Why do you think pharmaceutical companies have a responsibility for disaster relief? Damonti: […]

A Connected Healthcare Life

October 1, 2017

Three years ago, Verily — then a division of Google X — unveiled its Baseline Project, a collaboration with Duke University and Stanford University to collect health data from healthy people to get a sense of what “normal” looks like. Earlier this year, the group began the process of enrolling 10,000 healthy people, over the […]

A Rare Journey: Managing the Regulatory Landscape

October 1, 2017

In 1983, Congress passed the Orphan Drug Act, bringing with it the opportunity to advance the development of drugs for rare diseases. Since that time, the Food and Drug Administration (FDA) has approved more than 550 products to treat rare diseases. The FDA established the Office of Orphan Products Development (OOPD) with a mission to […]

The Battle Against Infectious Disease

October 1, 2017

Epidemics of infectious diseases are a real and dangerous threat. Nowhere in the world have infectious diseases been addressed adequately to become a small portion of illness and death. The Ebola and Zika public health emergencies have brought to light that we are unprepared to detect, prevent, and treat pandemic infections. These outbreaks cost thousands […]

The Launch Pad Preparing for Product Launch

October 1, 2017

Launching a pharmaceutical product has never been easy, but in years past it was certainly simpler. The days of focusing singularly on high-decile prescribing docs and sending out an army of sales reps are a distant memory. Today’s marketers must establish a value story for physicians, patients, and payer stakeholders, and communicate that value effectively. […]

Solutions for Clinical Sites

October 1, 2017

Clinical study sites are transforming their technology infrastructures with the adoption of electronic medical records (EMRs). But while EMRs improve treatment-related tasks in healthcare settings, they have not helped to reduce the burden of clinical trial studies on the sites. A May 2017 survey shows that study sites remain burdened with mundane administrative tasks, such […]

What Do Millennials Want?

October 1, 2017

So much has been written about the Millennials. With the exception of Baby Boomers, Millennials are the most talked about and studied generation. Born roughly between 1981 and 1997 (depending on which survey you look at), this generation, we are told, thinks and behaves differently. Some 80 million strong, this generation grew up at a […]

SHOWCASE FEATURE: Patient Solutions: Responding to the Needs of the Savvy Patient

October 1, 2017

Responding to the Needs of the Savvy Patient When healthcare IT strategist Leonard Kish referred to patient engagement as the blockbuster drug of the century, he tapped into an important realization: that the patient has to be at the center of everything a pharmaceutical company does. Today’s patients are increasingly savvy and engaged in their […]

A Roadmap for Patient-Centric Patient Support Programs

October 1, 2017

Patient-centricity is widely embedded into the mission statements and values of biopharma organizations. It gives purpose and urgency to efforts across research, development, and commercialization. Yet patient-centricity often is vaguely defined — making the goal hard to achieve. Teams striving for patient-centricity could use a roadmap. A workgroup involving advocates and caregivers recently published an […]

Precision Medicine Meets Precision Patient Support

October 1, 2017

In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary for patient compliance — behaviors that are difficult to influence, track or control without proper patient insights and ongoing […]

Impact Patient Outcomes Without Talking to the Patient

October 1, 2017

Patient marketers are used to providing valuable patient services and information directly to patients. But if the goal is to accelerate patient outcomes, the needs of the caregiver should also be addressed. Patient marketers know that caregivers play an important part in patients’ lives, but they often don’t see caregivers as having a direct impact […]

The Connected Consumer

October 1, 2017

At some point during the far-off days of the Carter administration, Carnegie Mellon expanded its Computer Science department, leaving programmers farther away from the department’s only Coke machine. So rather than trek down a couple of floors only to find an empty vending machine, or worse, a machine recently loaded with still-warm soda, they figured […]

SHOWCASE FEATURE: Supply Chain: The Supply Chain of the Future

October 1, 2017

Analysts say reimagining processes to take advantage of advanced connectivity can be a supply chain differentiator in the future. The pharmaceutical supply chain, one of the most complex in any industry silo, is also one of the most inefficient and ill-equipped to cope with products in the pipeline, according to analysts at PwC. The pharm […]

Driving Access and Efficiency with a Direct-to-Physician Sampling Program

October 1, 2017

For commercial teams at pharmaceutical companies, reaching physicians with product messaging has never been more challenging. In fact, according to 2016 research from AccessMonitor1, only 44% of physicians, were considered accessible to pharmaceutical sales representatives — a decline from 80% in 2008. And one in five of all physicians “severely” limit access to reps. Given […]

FEEDBACK